logo IDIBELL
Cat  |   Cas  |   Eng
Search
The InstituteResearchWhat's onPlatformsJoin usTools
 

News

boto imprimir
Date: 01/02/2018

Àlex Vaquero is awarded 200,000 euros from Worldwide Cancer Research to better understand the origin of cancer


Dr. Àlex Vaquero, leader of the chromatin biology research group of the Bellvitge Biomedical Research Institute (IDIBELL), has been awarded one of the prestigious grants from the Worldwide Cancer Research organization,  worth 200,000 euros. The grant will fund a new project of this basic research group focused on the study of the mechanisms of tumor formation.

 

The project led by Dr. Vaquero, entitled "Dissecting the specific contribution of Sirtuin ADP-ribosyltransferase and deacetylase activities in tumorigenesis", will last 36 months starting this February. The research aims to understand how a group of enzymes, known as Sirtuins, plays a role in the formation of tumours, in order to uncover ways to target them for cancer treatment.

 

The sirtuins are enzymes involved in the cellular response to stress. Certain stress conditions are very relevant as they have been shown to contribute to tumour development.. However, the role of sirtuins is complex, which is partly due to the fact that some sirtuins show two distinct enzymatic activities, sometimes opposite. Dr Vaquero wants to understand this enzymatic diversity and the specific contribution of each of these activities to the role of Sirtuins in cancer.

 

"This financial aid will mainly serve to hire a post-doctoral researcher who will be exclusively dedicated to this project," says Dr. Vaquero. This year, the call for grants has received 750 proposals, of which only about twenty (3%) have been selected, including the IDIBELL group project.

 

Worldwide Cancer Research (formerly AICR) is a charity that funds research on any type of cancer at the international level through an annual call for highly prestigious grants. The goal of this organization is to recruit the best research talent from around the world to develop better and more effective cancer treatments.

Dr. Àlex Vaquero, leader of the chromatin biology research group of the Bellvitge Biomedical Research Institute (IDIBELL), has been awarded one of the prestigious grants from the Worldwide Cancer Research organization,  worth 200,000 euros. The grant will fund a new project of this basic research group focused on the study of the mechanisms of tumor formation.

 

The project led by Dr. Vaquero, entitled "Dissecting the specific contribution of Sirtuin ADP-ribosyltransferase and deacetylase activities in tumorigenesis", will last 36 months starting this February. The research aims to understand how a group of enzymes, known as Sirtuins, plays a role in the formation of tumours, in order to uncover ways to target them for cancer treatment.

 

The sirtuins are enzymes involved in the cellular response to stress. Certain stress conditions are very relevant as they have been shown to contribute to tumour development.. However, the role of sirtuins is complex, which is partly due to the fact that some sirtuins show two distinct enzymatic activities, sometimes opposite. Dr Vaquero wants to understand this enzymatic diversity and the specific contribution of each of these activities to the role of Sirtuins in cancer.

 

"This financial aid will mainly serve to hire a post-doctoral researcher who will be exclusively dedicated to this project," says Dr. Vaquero. This year, the call for grants has received 750 proposals, of which only about twenty (3%) have been selected, including the IDIBELL group project.

 

Worldwide Cancer Research (formerly AICR) is a charity that funds research on any type of cancer at the international level through an annual call for highly prestigious grants. The goal of this organization is to recruit the best research talent from around the world to develop better and more effective cancer treatments.





foto Dr. Àlex Vaquero
Dr. Àlex Vaquero

Share/Bookmark
 
© 2018 IDIBELL



Results by pageInitial date
Select date
TitleFinal date
Select date
Search


Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL�s web applications

New password:
Confirm new password:

Accept



Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL�s web applications

New password:
Confirm new password:

Accept


Cancell

Passwords doesn�t match
The password must have at least 6 characters
The new password can not contain special characters
User register

Name
Surname
Second Surname
E-mail
User
Password
Language


Accept


Cancell




Encara no heu contestat l'enquesta de satisfacci� sobre la p�ndola formativa sobre patents. No trigareu m�s de cinc minuts a fer-ho. La vostra opini� �s molt important per millorar l�IDIBELL.

Voleu fer l�enquesta ara?

Yes

No




Further personal and contact information is needed to maintain IDIBELL databases.

Do you wish to fill the form now?

Yes

No





Please, remember to introduce your holiday�s planning in the application

Accept

Cancell